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Abstract 
Veterans at the White River Junction Veterans Affairs Medical Center (WRJVAMC) are 
screened annually for mental health disorders. Depending upon the severity, patients who screen 
positive may be treated in up to 3 settings: Primary Care (PC), Primary Mental Health Care 
(PMHC) clinic and/or Specialized Mental Health Care (SMHC) clinic. PMHC is an innovative 
clinical setting at the WRJVAMC that integrates mental health with primary care. The particular 
subset of patients we consider are those newly identified with Major Depressive Disorder 
(MDD), Post-Traumatic Stress Disorder (PTSD), or Alcohol Abuse through a yearly screening 
program in PC. This project assesses care for this subset of patients across two dimensions: 
receipt of any mental health care and how care setting influences the quality of care. 
For patients who screen positive, the VA currently needs an established standard to 
evaluate whether patients subsequently receive an effective course of treatment with  medication 
and/or psychotherapy. The target population consists of veterans who screened positive in Fiscal 
Year (FY) 2011 and received treatments in (1) PC only, (2) PC and PMHC only, or (3) PC, 
PMHC and SMHC. We used administrative and pharmacy data from the VA over FY 2010, FY 
2011, and FY 2012 to develop and implement a quality scale (rated 0 to 5) to track treatment 
quality for patients in our target population. According to our analyses, patients who utilized the 
PMHC or SMHC had higher quality ratings. The majority of patients did not receive treatment, 
and were seen only in PC and did not receive treatment.  
It appears that obtaining mental health services in the PMHC or SMHC increases the 
quality of mental health treatment.  Patients seeking treatment from specialty mental health 
providers enter treatment through the PMHC and progress to the SMHC if needed.  Because so 
few patients received treatment in these settings, we used a discrete-event simulation model of 
the PMHC to estimate workforce requirements to see all patients in the PMHC while minimizing 
impact on patient wait times and staff utilization. 
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Problem Statement 
Veterans at the White River Junction Veterans Affairs Medical Center are screened 
annually for Major Depressive Disorder (MDD), Post-Traumatic Stress Disorder (PTSD), and 
Alcohol Abuse. Patients who screen positive may be treated in Primary Care (PC), Primary 
Mental Health Care (PMHC) clinic, the Specialized Mental Health Care (SMHC) clinic, or not at 
all. Our goal was to establish a method to determine whether patients with positive mental health 
screens receive treatment and whether receiving care from mental health clinicians results in 
improved treatment quality. Patients obtain care from a mental health clinician by presenting to 
the PMHC.  We provided estimates of the workforce needed to see all patients with a new 
positive mental health screen in the PMHC clinic. 
  
8 
 
Goal Statement 
Our goal is to aid the VA on improving operations of mental health services by ensuring 
that adequate treatment is provided to patients with acceptable clinic access. In order to tackle 
this goal, we concentrate on assessing the quality of treatment provided to mental health patients. 
We utilize a scale where mental health patients are categorized into different quality levels 
depending on the duration and type of treatment provided. We aim to determine which clinic 
setting has the most patients with the highest quality ratings for each type of treatment (i.e. the 
setting that provides the highest level of care to the mental health patients for a specific 
disorder). 
Our secondary focus is to determine the staffing levels needed at the Primary Mental 
Health Care (PMHC) clinic to provide treatment to a larger patient population while preserving 
current performance of the clinic. We utilize a simulation model to recommend the optimal level 
of workforce required for the PMHC clinic if patients currently not receiving treatment and 
patients receiving treatment in only Primary Care were to receive treatment in the PMHC clinic.   
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1. Introduction 
A significant number of veterans experience mental health disorders as a result of a high-
stress atmosphere associated with military service and combat. It is estimated that more than 1.5 
million out of 5.5 million veterans seen in 2009 had a mental health diagnosis [1]. The impact of 
a high-stress environment usually remains even after a tour of service. Psychological conditions 
such as post-traumatic stress disorder (PTSD), alcohol abuse and depression are common mental 
health problems observed within the veteran population. As many veterans need support and 
treatment to recover, the Veterans Health Administration (VHA) provides them with primary 
care and mental care services. 
The VHA functions within the United States Department of Veteran Affairs and provides 
veterans with services in facilities such as clinics, medical centers, hospitals, and nursing homes. 
Services commonly offered at medical centers include surgeries, orthopedics, mental health, and 
many other forms of health care. These facilities as well as other clinics, community living 
centers, and independently licensed health care practitioners provide care to over five million 
veterans each year [1]. 
The New England VA Healthcare System is a network of services which consists of 
various medical centers around six New England states. One of these medical centers is the 
White River Junction VA Medical Center, which was awarded the American Psychiatric 
Association’s gold achievement award and the Secretary of Veterans Affairs Advanced Clinical 
Access notation champion award due to implementing outstanding and innovative mental health 
programs to provide better treatment opportunities to its patients [2]. The medical center is well 
known for the implementation of the “Primary Mental Health Care (PMHC)” model, which was 
initiated in 2004. This model concentrates on treating patients with mental health conditions 
within primary care settings in order to conserve scarce mental health treatment resources [2]. 
The model consists of an integrated clinic which functions within primary care and offers care 
management, specialty expertise and chronic disease management. Partly due to the success of 
the PMHC model, VA medical centers began to receive additional funding in 2007 to implement 
and maintain integrated care models.  
In order to fully satisfy the mental health needs of primary care patients, the White River 
Junction Medical Center places mental health clinicians in the primary care setting.  VA primary 
care staff are organized in groups called Patient Aligned Care Teams (PACT). PACTs 
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concentrate on providing comprehensive and continuous care to veterans in order to address all 
of the medical, behavioral and psychosocial issues faced by these patients. The patients are first 
examined and treated by primary care providers (PCP) who later collaborate with experts in 
other health units to provide additional expertise [3]. This area is the focus of our work, namely 
the screening processes that assist the clinic in identifying and addressing needs of primary care 
patients. Adequate screening and treatment techniques are fundamental to the effectiveness of 
the VA Medical Center at White River Junction. 
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2. Background 
2.1 Primary Care 
Primary care pilot programs began at VA medical centers in the 1980s and early 1990s 
[4]. Primary care is widely seen as the anchor for integrating and coordinating care delivery [4]. 
It is the first source of contact for patients and provides continuity of care; however, only 
approximately 10% of VA health care users were enrolled in primary care at the end of fiscal 
year (FY) 1994 [4]. Implementation of primary care faced opposition from the specialist-
dominated culture of many VA hospitals. The VA went through major reengineering during the 
1990s [4] to focus on one of its biggest problems—fragmentation, which is why the VA 
launched a primary care initiative in FY 1995 to focus on the patient and coordinate better use of 
the VA healthcare system for the patient [4]. Implementation of primary care is one of the three 
factors most linked with improved service satisfaction (the other two factors being reduced 
waiting times and improved access to care through Community Based Outpatient Clinics—
CBOCs) [4].  
 Today, primary care is the cornerstone of VA care and almost all VA users are assigned 
to a primary care clinician.  The VA is redesigning primary care into interdisciplinary teams that 
will focus on veteran-centered care. This Patient Aligned Care Team initiative aims to provide 
better care for patients by having specialists and primary care physicians collaborate to provide 
whole, non-fragmented care. The Core PACTs include the PCP, a Registered Nurse (RN), Care 
Manager, Clinical Associate, and Clerk [5]. The Expanded Team includes different specialties 
including mental health (MH) professionals. Patients are screened yearly for depression, suicidal 
tendencies, PTSD, alcohol abuse, and traumatic brain injury [2]. A parallel initiative the VA has 
been undertaking is the integration of primary care and mental health services. The Primary 
Care-Mental Health Integration initiative aims to improve patients’ access to care and improve 
quality of patient care. 
2.2 Primary Care Mental Health Integration 
Treating mental health problems solely in the primary care setting has become a popular 
practice since the development of new psychotropic medications [6]. Approximately 42% of the 
25,658 mental health diagnoses for Operations Enduring Freedom (OEF) and Iraqi Freedom 
(OIF) veterans were first made in primary care settings. Detecting mental health disorders in 
early stages and intervening in primary care can prevent chronic mental illnesses and disabilities 
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[7], which is one reason why the integration of mental health care into primary care is 
increasingly important. Two other reasons why primary care and mental health care should be 
integrated are that (1) primary care detection and treatment may be inaccurate or insufficient and 
(2) patients receive better treatment in a co-located health care setting.   
Primary care may fail to detect mental health problems in patients or may misattribute mental 
health problems as physical illnesses [8]. Having an integrated clinic will increase detection and 
diagnostic accuracy [8]. Patients with mental health disorders can be treated in just primary care; 
however, for certain patients that may not be effective. Studies have shown that care for 
depression in primary care is no longer acceptable [9]. Primary care physicians do not have 
sufficient time to treat patients in the acute phase of depression. The use of a care manager along 
with consultation or co-treatment with a mental health specialist allows the PCP “to fulfill 
depression screening recommendations more comfortably, formulate depressive diagnoses more 
aggressively, and manage depressive episodes more effectively”  [9].   
Integration of primary care and mental health provides better care than treatment in separate 
settings. Patients prefer to receive mental health care in the primary care setting so integrating 
mental health services in primary care results in patients being more compliant to mental health 
treatment. Receiving care in the primary care context enables better integration of care, in which 
the primary care provider and the mental health provider(s) can share diagnostic information, 
collaborate on treatment plans, and follow the overall health and well-being of the patient [8]. 
Clinics worldwide can potentially provide better care for their patients if they integrate mental 
health specialists into their primary care.  
2.3 Mental Health 
Studies have shown that there are high rates of mental health disorders – such as PTSD, 
depression, and alcohol use – among active duty military personnel and veterans of Operation 
Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) [10-13]. Between 2002 and 2008, 
sixty-two percent of veterans who were screened for mental health issues were diagnosed with 
PTSD which was the most common disorder [13].  
To promote early identification of mental health disorders among all service members 
returning from deployment, the Department of Defense initiated population-level screening at 
two points in time: immediately on a veteran’s return to the US, and 3 to 6 months after the 
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return [12, 14]. Among the veterans whose responses resulted in a positive screen, only 23 to 
40% actually received treatment [10, 15]. 
Even though there is still a significant percentage of veterans that are not receiving 
treatment, VHA specialty mental health contact has been growing approximately 9% per year on 
average since 1997 [16]. Around 41% of the  837,458 eligible OIF and OEF veterans have been 
enrolled in the VA since 2002 – a historically high rate compared to the 10% of Vietnam 
veterans – and the percentage of OIF and OEF veterans enrolled has been increasing ever since. 
[13].  
As the rate of mental health diagnoses increases and veterans utilize mental health 
services more, the VA will likely face logistical and financial challenges if new cases emerge 
and unresolved disorders become chronic [16, 17]. To treat chronic mental health disorders and 
to accommodate every veteran seeking mental health treatment, the VA needs to adjust its 
workforce size as well as improve the efficiency and quality of existing workforce in both 
primary care and mental health care settings. 
2.4 Simulation Modeling Literature Review 
Discrete-event simulation is one of the many tools used for analyzing and improving 
healthcare systems. It allows the modeling of complex processes or systems over time. As 
applied to health care, simulation provides a way to see how changes to a hospital (e.g. changes 
in layout, resources, work schedules, etc.) will affect the flow of patients. In the 2000’s, there 
have been over 100 papers in healthcare simulation each year - with over 500 in both 2005 and 
2007 [18]. Although there have been many simulation studies of Emergency Departments (ED) 
(including those that use simulation to address different levels of urgency of a patient visit) [19, 
20], despite proliferation of this method in healthcare, there are limited simulations and related 
studies based on mental health clinics.  
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3. Methodology 
We assessed the quality level of mental health treatment by developing and following a 
set of methods. In order to identify the current conditions and collect relevant data, we observed 
the daily mental health operations at the VA White River Junction Medical Center for three days. 
Our observations during the clinic visit and discussions with the project sponsors helped us 
determine which data should be pulled from the VA data depository. This data was cleansed to 
get rid of inconsistent or irrelevant records. During our data collection and organization, we 
referred to the data security training we received from the VA to ensure that there was no 
violation of mishandling patient or clinic data. Applying the above mentioned steps sequentially 
allowed us to obtain a clean dataset to identify the target patient population. 
By following the guidelines provided to us by our project sponsors, we determined the 
target patient population which was the initial step for implementing quality assessment. We 
assigned quality ratings to all the patients in the target population by utilizing quality scales that 
have varying criteria depending on the type of mental health disorder. The patients were 
categorized by the care setting they received treatment at as well as the mental health 
condition(s) they screened positive for. We reflected the data obtained from the quality 
assessment in descriptive tables and diagrams in order to illustrate the results more effectively. 
 In order to satisfy our second project goal which is to identify the changes needed at the 
PMHC clinic, we utilized a previously created simulation model to test various scenarios. By 
doing so, we identified the optimal number of staff needed to provide treatment to more patients 
while preserving the performance of the clinic. 
3.1 Clinic Observation 
Before conducting extensive data analysis, we observed the White River Junction 
Medical Center clinics for three days. We examined the daily operations for mental health 
services in different care settings. This allowed us to evaluate the current conditions and identify 
the data relevant for our analysis. The two psychiatrists, Dr. Brian Shiner and Dr. Bradley V. 
Watts, and a primary care physician named Dr. Anne Jones-Leeson provided us with overviews 
for PMHC clinic and PACT teams in PC, respectively.  
 During the primary care clinic visit, we accompanied two PACT teams who explained to 
us how to interpret the mental health screening results. We noted that some screenings resulted in 
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false positives (when a patient tests positively although they do not actually have a mental health 
disorder). 
During the PMHC clinic visit, we observed clerk and physicians in the clinic and 
accompanied some patients, with their consent. During our time at the clinic, the therapist and 
prescriber interviewed most of the new patients simultaneously before the patient would meet 
with the prescriber separately. However, this case is not typical in a normal workday and not 
reflected in our simulation model.   
3.2 Data Retrieval  
We collaborated with engineers at the New England Veterans Engineering Resource 
Center (VERC) to obtain data from the Corporate Data Warehouse (CDW) which is a repository 
for VA data.  The initial list of data fields was established by Dr. Brian Shiner and expanded 
upon by our team and the VERC engineers. After initial queries of the tables for patient 
demographics and pharmacy data, the following data acquisitions were specified to obtain only 
patients who: 
 Tested for at least one mental health assessment 
 Were veterans (patients could potentially also be family members of veterans) 
 Were not test patients (these are dummy records created during training) 
 Had a visit at WRJ or one of its CBOCs 
 Did not expire during the timeframe of the study.   
The list of tables created (which data fields were used in our analyses and what the tables were 
used for) can be found in Appendix A. Constraints were included in queries to obtain the data of 
only the patients who met the criteria listed above.  Additional constraints were included to 
obtain only patient records that meet other specifications such as the visit had to have certain 
Current Procedural Terminology (CPT) codes or certain medications (See Appendix B). 
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3.3 Data Analysis 
3.3.1 Data Cleansing 
We removed data that were inaccurate, inconsistent, incomplete, or duplicated. We also 
standardized the data to have the same vocabulary (e.g. transforming the text fields in the 
pharmacy data). We did not distinguish the specific times of the day when the patients should 
have taken their medication; only the amount of medication recommended per day was taken 
into consideration. Some of the data entered in the system was not clear due to entry errors.  
We eliminated:  
 patients who died during the timeframe of our data analysis 
 duplicate data records 
 test (fake records created for teaching purposes) patients  
Much of the data cleansing we intended to do was done through our data request.  
The types and amount of drugs were determined through text analysis of the signa (SIG 
field)—directions on how to take medication. We determined the daily dose by manually parsing 
the SIGs and recording the number of drugs taken daily, the frequency (times per day) the drug is 
taken, whether the prescription requires the patient to take the drug or not (drugs to be taken as 
needed were not considered for the quality scale) and whether the prescription is a titration 
(changes in dosages by time) or not.   
 
3.3.2 Data Security  
After receiving encrypted de-identified data from the VA, we decrypted and stored these 
files on WPI’s secure research server and analyzed the data using WPI-owned computers. Upon 
completion of our data analyses, we permanently deleted the files from the secure WPI server in 
order to prevent any unauthorized parties from accessing the data in the future.
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3.3.3 Identifying Target Population 
The target population consists of patients who screened positive in fiscal year 2011, but 
did not receive the adequate amount of mental health treatment (1 inpatient encounter or 2 
outpatient encounters) in fiscal year 2010. These patients are also distributed into three different 
categories depending on the clinics they visited. In order to identify the target population, the 
team determined all the patients who took at least one of 
the following mental health screening tests: PHQ-2 for 
MDD, PC-PTSD for PTSD and AUDIT-C for alcohol 
abuse in fiscal year 2011. Patients whose scores were 
lower than a certain threshold, which is different for each 
test, were excluded. Patients who were not excluded—
those who tested positive—were checked for whether 
they received any treatment prior to the date of the 
positive screen. Any patient who had at least one 
inpatient visit or 2 outpatient visits related to mental 
health between the start of fiscal year 2010 and the date 
of the positive screen were excluded. Remaining patients 
either received treatment in different care settings—PC, 
PMHC, and SMHC—or did not receive any treatment at 
all after the date of positive screen. Patients of interest 
were the ones who visited 1) PC only, 2) PC and PMHC 
only, 3) PC, PMHC, and SMHC. These patients make up 
the target population. The logic for identifying the target 
patient population is illustrated with the flowchart in 
Figure 1. 
 
 
 
Figure 1: Logic Diagram for Identifying Target Population
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3.3.4 Quality Scales for Medication and Psychotherapy 
We used a quality scale for mental health treatment created by our sponsor Dr. Brian 
Shiner to assign quality ratings to patients on a scale of 0 to 5. The criteria for the quality scale 
vary depending on the type of mental health disorder—MDD, PTSD, and Alcohol Abuse—and 
the type of treatment—medication and psychotherapy. 
3.3.4.1 Medication Quality Ratings  
The medication quality scale assesses whether patients received guideline recommended 
medication and whether patients were prescribed the minimum suggested dosage of medication 
for an adequate duration. Patients commonly try several medications, which is accounted for in 
the quality scale. We utilized pharmacy data that belongs to our target population in order to 
assign quality ratings. We only used records from the date of a patient’s positive screen to the 
end of FY 2012. The data showed the dates the drugs were issued and dispensed, as well as days 
of supply, dosage, dispense unit, SIGs and strength. Prescriptions for each patient prior to the 
date of positive screen were excluded. 
Rating Definition 
0 No Treatment 
1 Any Psychiatric Medication 
2 Guideline-Recommended Psychiatric Medication 
3 Adequate Total Daily Dose 
4 Adequate Duration 
5 2 or More Trials Rated 4 or Higher  
Table 1: Medication Quality Rating Criteria 
Patients who received any psychiatric medication were assigned quality rating 1. The 
data for all the psychiatric medication prescribed were derived from the pharmacy data 
workbook which was provided to us by our VA project sponsors and listed in the table in 
Appendix B. 
The rest of the patients were assigned rating 0 which means they did not receive any 
mental health medication although they screened positive. If patients with quality rating of 1 
received medication recommended by VA guidelines irrespective of the dosage, they were 
assigned a quality rating of 2. The list of guideline—recommended medication is different for 
each mental health disorder as listed in the tables below.  
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MEDICATIONS RANK 2 RATING CRITERIA 
PTSD Guideline-Recommended 
Psychiatric Medication 
Citalopram Escitalopram Fluvoxamine Sertraline 
Duloxetine Fluoxetine Paroxetine Venlafaxine 
MDD Guideline-Recommended 
Psychiatric Medication 
Amitryptline Escitalopram Nortriptyline Trazodone 
Bupropion Fluoxetine Fluvoxamine Venlafaxine  
Citalopram Imipramine Paroxetine   
Desipramine Isocarboxazid Phenelzine   
Doxepin Mirtazepine Selegiline   
Duloxetine Nefazedone Sertraline   
Alcohol Abuse Guideline-
Recommended Psychiatric 
Medication 
Naltrexone       
Acamprosate       
Table 2: Medications Rating 2 Criteria for MDD, PTSD and Alcohol Abuse patients 
 In order to analyze the medication data, three quality scale tables were created, one for 
each mental health disorder—MDD, PTSD, and Alcohol Abuse. Patients who tested positive for 
multiple disorders were included in more than one table. We utilized a specific set of criteria for 
each mental health disorder. In order to do so, we filtered out the medications that were not used 
to treat the specified mental health disorder. To determine the patients from the target population 
who should be assigned a quality rating of 3, Adequate Total Daily Dose, we transformed the 
SIGs to the number of drugs taken per day, Thus we were able to see if the daily doses 
prescribed were sufficient to categorize patients for a rating of 3. We determined which records 
were titrations (different amounts to be taken after a certain amount of days) and dealt with them 
separately. In order to incorporate the prescriber notes, we filtered the data and found 529 unique 
notes in the data set, 179 of which were titrations. We utilized the notes to determine the daily 
number of pills taken for each unique note. We multiplied the strength values of each drug 
prescribed, in milligrams, with daily number of pills taken and acquired the values for daily 
doses. Patients who received adequate total daily doses were assigned a quality rating of 3. 
 Although it was not in our data sets (after separating the patients and filtering for disorder 
specific medication), Selegiline would have been an exception in the data analysis due to the 
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nature of the way it is prescribed. Selegiline is a drug that could be prescribed in patches because 
it can be taken transdermally. Another medication that would have been an exception was 
Fluoxetine which could be prescribed either as 20 milligrams per day or 90 milligrams per week. 
If a patient was prescribed 90 milligrams per week which is the suggested minimum dosage, then 
the patient qualified and was placed under quality rating of 3—Adequate Daily Dosage. All of 
the patients who were taking Fluoxetine received the required daily dose; therefore, there was no 
need to check for the required weekly dosage. 
MEDICATIONS RANK 3 RATING CRITERIA 
PTSD Medications 
Adequate Total 
Daily Dose 
Citalopram 20 mg Escitalopram 10 mg Fluvoxamine 150 mg 
Duloxetine 60 mg Fluoxetine 20 mg Paroxetine 20 mg 
Sertraline 100 mg Venlafaxine 150 mg   
MDD Medications 
Adequate Total 
Daily Dose 
Amitryptline 200 mg Doxepin 200 mg Imipramine 200 mg 
Bupropion 300 mg Duloxetine 60 mg Isocarboxazid 41 mg 
Citalopram 20 mg Escitalopram 10 mg Mirtazepine 30 mg 
Desipramine 200 mg 
Fluoxetine 20 mg daily 
or 90 mg weekly 
Nefazedone 300 mg 
Nortriptyline 76 mg Fluvoxamine 200 mg Paroxetine 20 mg 
Phenelzine 61 mg 
Selegiline 41 mg oral 
or 6 mg transdermal 
Sertraline 100 mg 
Trazodone 400 mg Venlafaxine 225 mg   
Alcohol Abuse 
Medications 
Adequate Total 
Daily Dose 
Naltrexone 50 mg oral daily 
Naltrexone 380 mg intramuscular monthly 
Acamprosate 1998 mg 
Table 3: Medications Rating 3 Criteria for MDD, PTSD and Alcohol Abuse patients 
Patients who were assigned a quality rating of 4 were determined by examining the 
duration of treatments provided to rating 3 patients. The treatment duration should be 8 weeks or 
more for PTSD and 4 weeks or more for MDD and alcohol abuse. We examined the daily supply 
of medication as well as the duration of prescription to determine if the total medication received 
matches the required amount. Patients for whom these values match were assigned a quality 
rating of 4. Patients who received different amounts of the same medication during different 
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timeframes—titrations—and refills were examined more carefully. We analyzed the prescription 
information for rating 4 patients. If a patient refilled a prescription that met the adequate dosage 
and duration, then that patient was assigned a quality rating of 5. The refill was counted as a 
second trial.  
 
3.3.4.2 Psychotherapy Quality Ratings 
MDD or PTSD PSYCHOTHERAPY RATING CRITERIA   
Rating Definition Use 
0 No Treatment No Treatment 
1 Any Individual Psychotherapy CPT Code 
90804, 90806, 90808, 
90810, 90812, 90814, 
90845, 90875, 90876, 
96152 
2 Any Psychotherapy CPT Code 45 minutes or Greater 
90806, 90808, 90812, 
90814 
3 8 or more sessions with the same provider Use Provider ID 
4 8 or more sessions over a 14-week period Earliest 98-day period 
5 2 or more trials rated 4 or higher   
Table 4: Psychotherapy Rating Criteria for MDD and PTSD Patients 
Quality ratings for psychotherapy were assigned only to patients with PTSD or MDD 
because those with Alcohol Abuse did not receive psychotherapy treatment. In assigning the 
psychotherapy ratings, we used outpatient visits data which showed the dates of each patient’s 
visits and the CPT codes for procedures that he or she received during each visit. 
Patients who had visits with any psychotherapy CPT code were assigned a quality rating 
of 1; the rest were assigned 0 which means they did not receive any psychotherapy treatment. 
Those who received psychotherapy treatment 45 minutes or more were assigned a rating of 2. 
We analyzed Provider SIDs (Provider ID) to count the number of times each patient visited the 
same provider. Patients with a quality rating of 2 who received treatment with the same provider 
for 8 or more times were assigned a quality rating of 3. Patients with a quality rating of 3 who 
received treatment for 8 or more times within a 14-week period were assigned a rating of 4. We 
used visit dates to determine whether a patient meets this criterion. If rating 4 patients had 2 or 
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more trials of such rating (i.e. if there were 2 or more instances where they received 8 or more 
psychotherapy treatments of at least 45 minutes within 14 weeks), they were assigned a rating of 
4.  
The logic behind these analyses for assigning medications and psychotherapy ratings to 
mental health patients is explained in the logic chart presented in Appendix B. 
3.3.7 Descriptive Statistics 
We calculated descriptive statistics (mean, median, mode, standard deviation, and other 
measures that explain our data) that described the patients in our target population using 
Microsoft Excel. 
 To determine the numbers that describe the medication ratings for each patient disorder 
type (MDD only, PTSD only, Alcohol Abuse only, MDD & PTSD, MDD & Alcohol, PTSD & 
Alcohol, and MDD & PTSD & Alcohol), we used the Descriptive Statistics procedure in the 
Excel Analysis ToolPack.  
 Frequency distribution tables 
 Mean, median, mode 
 Sample standard deviation, range 
 Number of patients who screened positive for: 
o Depression Only 
o PTSD Only 
o Substance Abuse Only 
o Depression and PTSD 
o Depression and Substance Abuse 
o PTSD and Substance Abuse 
o Depression, PTSD, and Substance Abuse 
3.4 Simulation 
Discrete-event simulation is commonly used to model the flow of patients in outpatient 
clinics as it is a useful tool to analyze scheduling and capacity planning [18]. We utilized a 
discrete-event simulation model of PMHC clinic at the White River Junction VA Medical Center 
to estimate how patient-volume changes would affect wait times of patients and utilization of 
mental health care workforce. Usually, there is a trade-off between wait times and resource 
utilization. Using too many resources to reduce wait times leads to underutilized resources and 
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unnecessary costs. Using too few resources increases wait times and keeps resources overly 
occupied. We used the simulation model to find the optimal level of workforce capable of 
providing treatment to a larger patient population without having patients wait significantly 
longer. 
The potential increase in patient volume as determined from the screening data serves as 
the input for the model. From our data analysis, we found that the number of patients with new 
positive mental health screens who were seen only in PC during FY 2012 was approximately 
twice the number of patients who visited PMHC clinic. We increased the current patient arrival 
rates accordingly to predict how clinic performance would be affected if all patients from PC 
with new positive mental health screens were referred to PMHC. In increasing the arrival rates, 
we assumed that new patients, on average, would visit the PMHC clinic as frequently as those in 
FY 2012. We ran a total of four different scenarios as summarized in the table below. 
 Patient Arrival Rate Resource Capacity 
Base Scenario Current Current 
Increased Patient Volume Increased to approximately 3 
times of current rate 
Current 
Additional Prescriber and 
Therapist I 
Increased to approximately 3 
times of current rate 
1 additional prescriber and 
therapist 
Additional Prescriber and 
Therapist II 
Increased to approximately 3 
times of current rate 
2 additional prescribers and 
therapists 
Table 5: Four Different Scenarios in Simulation 
The Base Scenario was run with patient arrival rates (shown in Appendix) for FY 2012 
and current capacity of resources. The resources included in the model are:  
1. Clerk, who interacts with patients for registration  
2. Tablet, which patients use to take mental health surveys 
3. Prescriber, who is responsible for prescribing medication 
4. Therapist, who is responsible for psychotherapy treatment 
5. Care Manager, who follows up with patients to check their status 
Currently, the clinic operates with 1 clerk, 2 tablets, 1 prescriber, 1 therapist, and 1 care 
manager. The “Base Scenario” uses the same amount of resources and arrival rates to reflect the 
current situation. In other scenarios, the arrival rate was increased to include patients from PC. 
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We considered additional scenarios only after analyzing the results of the Base Scenario. 
Therefore, instead of considering many possible combinations of increased resource capacities, 
we only considered increasing the capacities of those whose performance was significantly 
reduced. In the scenarios “Additional Prescriber and Therapist I” and “Additional Prescriber and 
Therapist II”, the numbers of prescribers and therapists were increased by 1 and 2 respectively. 
We initially ran the Base Scenario with 10 replications and observed the results. Using the 
results of this simulation run, we estimated that 50 replications would reduce the values of the 
95% confidence interval to be +/-0.01 (hours) of the average wait times. These 50 replications 
also would not significantly hinder run time. Each of the replications was run for 130 simulation 
days to represent 26 work weeks (half a year). Initially, the input data for the model was based 
on 6 months of data so the initial run-length of the model was set to reflect this. Although we 
analyzed additional data and used patient arrival rates for the duration of FY 2012, we did not 
consider it necessary to change the run-length. 
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4. Results and Analysis 
4.1 Target Population 
 The following graphs and charts show demographics of our target population. 
 
Figure 2: Age Range of Target Population 
 Figure 2 shows the age distribution of veterans in the target population. The distribution 
resembles a triangular distribution with the most frequent age range being 60 - 69. 
Approximately half of target patient population lies between 60 and 79. 
 
Figure 3 shows the gender 
distribution of the target 
population. More than 95% of 
veterans are male. 
 
 
 
Figure 3: Target Population by Gender 
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Figure 4 shows marital status of 
veterans. More than 80% of 
veterans are either married or 
divorced while about 11% have 
never married. 
 
 
 
 
 
Figure 4: Target Population by Marital Status 
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Figure 5: Target Population by Service Era 
Figure 5 shows the percentage of veterans that have served in various eras. The majority 
of our target population served in the Vietnam Era. A smaller percentage of our population 
served in World War II which makes sense since those veterans would be at least 80 years old.  
8.73% 
0.15% 
14.28% 
7.41% 
40.21% 
7.23% 
21.60% 
0.39% 
Service Era 
WORLD WAR II
PRE-KOREAN
KOREAN
POST-KOREAN
VIETNAM ERA
POST-VIETNAM
PERSIAN GULF WAR
OTHER OR NONE
28 
 
4.2 Relationship between Quality Ratings and Care Settings  
Each patient in the target population was categorized by care setting and assigned a 
quality rating for one or more mental health disorders. Patients with more than one mental health 
disorder were assigned multiple quality ratings – one for each disorder. For the purpose of 
simplicity, we will use only one clinic name to refer to each combination of care settings. 
Patients who are referred to as “PMHC patients” are the ones who received treatment in both 
primary care and PMHC. Patients who are referred to as “SMHC patients” are the ones who 
received treatment in all three care settings.  
Care Setting Referral 
PC PC patients 
PC + PMHC PMHC patients 
PC + PMHC+ SMHC SMHC patients 
Table 6: Simplified Reference for Patients by their Care Settings 
Table 7 consists of medication quality rating for MDD patients. Two hundred and 
fourteen patients (40.2% of MDD patient population) did not receive any mental health 
medication. On the other hand, 23.1% of the patients have a quality rating of 5 which indicates 
that these patients received the highest level of care. It can be easily seen that there are no 
patients with a quality rating of 3. This result shows that all patients who received an adequate 
daily dose of medication were also treated for at least an adequate duration. These patients were 
assigned a quality rating of 4.   
When the distribution of primary care patients is examined for each quality rating, it is 
observed that more than half of these patients did not receive appropriate medication. MDD 
patients with quality ratings of 4 or 5 form only 18.1% of the PC patient population, compared to 
45% of PMHC and 60.6% of SMHC MDD patients. 
In total, 45% of the MDD patients who are treated in PC and PMHC simultaneously have 
a quality rating of 4 or 5. Over 60% of the MDD patients who are treated in all three care settings 
have a quality rating of 4 or 5. This result shows that the services provided by PMHC and SMHC 
significantly increase the quality of mental health care treatments. 
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Medication Quality Ratings 
 
Table 7: MDD Medication Quality Ratings by Highest Level of Care Received 
It can be seen in Figure 6 that MDD medication patients with quality ratings of 0 or 1are 
less likely to have visited all three care settings. The percentage of patients who have visited all 
three care settings is higher for patients with quality ratings of 2, 4, and 5.  This statistic indicates 
that combining the resources available at all possible care settings might result in better 
treatment. 
 
Figure 6: MDD Medication Quality Ratings by Highest Level of Care Received 
The data analysis of medication quality ratings for PTSD patients provides us with results 
that parallel the findings for MDD medication patients. Almost 40% of PTSD patients did not 
receive appropriate medication – similar to the result for the MDD medication patients. 
Analogous to MDD patients, approximately 30% of the patients are distributed between quality 
ratings of 1 and 2. In this circumstance, patients with a quality rating of 1 account for 24.6% of 
MDD
0 188 54.81% 5 25.00% 21 12.35% 214 40.15%
1 48 13.99% 4 20.00% 10 5.88% 62 11.63%
2 45 13.12% 2 10.00% 36 21.18% 83 15.57%
3 0 0.00% 0 0.00% 0 0.00% 0 0.00%
4 21 6.12% 3 15.00% 27 15.88% 51 9.57%
5 41 11.95% 6 30.00% 76 44.71% 123 23.08%
Total 343 100.00% 20 100.00% 170 100.00% 533 100.00%
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the PTSD patient population. Patients of quality ratings 3 and 4 together account for more than 
10% of the PTSD medication patients. It is worth noting that 21.2% of the PTSD patients 
received the highest level of care for medication. This result aligns with the percentage obtained 
for MDD medication patients with a quality rating of 5 (23.1%).  
As the number of care settings involved in the treatment process increases, a higher 
number of patients with quality ratings of 4 or 5 is observed. Only 10.6% of the PC patients with 
PTSD diagnosis have quality ratings of 4 or 5 whereas this percentage increases to 33.3% for 
PMHC patients. In addition, 45.1% of the SMHC patients have quality ratings of 4 or 5. Thus we 
can say that for PTSD treatment, the percentage of patients who are provided services with 
higher quality increases as these patients are treated in higher level care settings. This result 
aligns with findings for MDD medication patients. 
The percentage of PC and PMHC patients with a PTSD diagnosis who did not receive 
any medication shows us that PTSD is better treated when specialized clinic is involved in the 
process. The percentage of untreated patients is reduced significantly from 57.5% and 42.9% to 
14.8% once the specialized clinic is involved. PTSD patients who receive treatment in PMHC 
and SMHC clinics in addition to primary care seem to receive a higher quality of treatment. 
 
Table 8: PTSD Medication Quality Ratings by Highest Level of Care Received 
Similar to the result obtained for MDD patients, PMHC patients (indicated by red in the 
bar graphs) form only a small percentage of the overall PTSD medication patient population. The 
majority of patients who are treated in primary care do not receive appropriate medication; 
however the majority of those treated in all three care settings receive at least the adequate 
amount of medication. Most PTSD medication patients are assigned quality ratings of 0 or 1 and 
the third largest patient group consists of patients with quality rating of 5. This result shows that 
PTSD
0 103 57.54% 9 42.86% 27 14.84% 139 36.39%
1 45 25.14% 5 23.81% 44 24.18% 94 24.61%
2 10 5.59% 0 0.00% 17 9.34% 27 7.07%
3 2 1.12% 0 0.00% 12 6.59% 14 3.66%
4 6 3.35% 3 14.29% 18 9.89% 27 7.07%
5 13 7.26% 4 19.05% 64 35.16% 81 21.20%
Total 179 100.00% 21 100.00% 182 100.00% 382 100.00%
Care Setting
TangScale
TotalPC PC+PMHC PC+PMHC+SMHC
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most of the patients are accumulated on either end of the quality rating scale. Figure 7 highlights 
quality ratings related to PTSD medication. 
 
Figure 7: PTSD Medication Quality Ratings by Highest Level of Care Received 
Our analysis for alcohol abuse treatments indicates that 76.4% of the patients did not 
receive any medication. Even though approximately 90% of all alcohol abuse patients attend 
solely primary care, more than 80% of those patients did not receive appropriate medication.  
 
Table 9: Alcohol Abuse Medication Quality Ratings by Highest Level of Care Received 
 The majority of patients (62.9% of the total PMHC and 73.8% of the total SMHC 
patients) have a quality rating of 1. This result shows that a large percentage of these patients 
who were treated in PMHC or SMHC received psychiatric medication; however, they did not 
receive the alcohol abuse medications recommended by VA guidelines. Table 9 shows that 
23.2% of the total patient population is composed of patients with a quality rating of 1 and very 
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0 2060 82.60% 13 37.14% 59 22.43% 2132 76.36%
1 433 17.36% 22 62.86% 194 73.76% 649 23.24%
2 0 0.00% 0 0.00% 0 0.00% 0 0.00%
3 0 0.00% 0 0.00% 0 0.00% 0 0.00%
4 1 0.04% 0 0.00% 4 1.52% 5 0.18%
5 0 0.00% 0 0.00% 6 2.28% 6 0.21%
Total 2494 100.00% 35 100.00% 263 100.00% 2792 100.00%
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few patients received treatments of quality rating 2 or higher. Figure 8 highlights quality ratings 
related to alcohol abuse medication. 
 
Figure 8: Alcohol Abuse Medication Quality Ratings by Highest Level of Care Received 
Psychotherapy Quality Ratings 
Table 10 shows that the majority of MDD patients, 66.8% of the total population, did not 
receive any psychotherapy treatment. The remaining 33.2% of the MDD patients received 
psychotherapy with 26.6% having quality ratings of 2 or higher. This result shows that the 
majority of the patients who received psychotherapy treatment attended psychotherapy sessions 
of 45 minutes or longer.  
As explained in the methodology section earlier, quality rating 3 stands for receiving 8 or 
more psychotherapy sessions with the same provider– continuity of care and quality rating 4 
stands for receiving these sessions over a 14 week period. In our data analysis, quality ratings of 
3 or higher each accounts for only about 2% of the total MDD patient population. For this 
reason, we can state that only a small percentage of patients received good continuity of care for 
psychotherapy treatments. 
The majority (99.7%) of MDD patients who attended primary care did not receive any 
psychotherapy treatment. Patients who visited primary care form about 64% of MDD patient 
population which is a high percentage and them not receiving treatment indicates a possible 
insufficiency of resources to provide such treatment. On the other hand, roughly 80% of PMHC 
patients have quality ratings of 1 or 2 and there are no patients with quality ratings of 3 or higher. 
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This means that PMHC patients received psychotherapy treatment but did not experience 
continuity of care. SMHC patients yield a similar result where 74.1% of them have quality 
ratings of 1 or 2 and 20% of the total SMHC patients have quality ratings of 3 or higher. This 
result indicates that only 20% of the SMHC patients experienced continuity of care. 
 
Table 10: MDD Psychotherapy Quality Ratings by Highest Level of Care Received 
As it can be seen from Figure 9, the majority of the MDD patients visited the primary 
care clinic but did not receive psychotherapy treatment. Most of the remaining patients received 
treatment in all three clinics. This patient group forms approximately 32% of the total MDD 
psychotherapy patients which is indicated by the green data series on Figure 9. 
 
 
Figure 9: MDD Psychotherapy Quality Ratings by Highest Level of Care Received 
 Half of the PTSD patient population did not receive any psychotherapy treatment as it 
can be seen from Table 11. Similarly to the MDD psychotherapy patients, rating 2 patients form 
the second highest percentage (~30%) of the PTSD psychotherapy patients. All of the higher 
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quality ratings each accounts for less than 5% of the total PTSD patients. This result might 
indicate that only a small percentage of PTSD psychotherapy patients received good continuity 
of care. 
Similar to the MDD patients, almost all of the PTSD patients (98.9%) who visited 
primary care did not receive psychotherapy treatment. These patients form only about 47% of 
total patient population which is less than the percentage of MDD patients (~64%) who visited 
only primary care. The majority of the PTSD patients (71.5%) who attended PMHC received 
psychotherapy treatment although there are no PMHC patients with quality ratings of 3 or 
higher. This result indicates that the PMHC patients who receive psychotherapy treatment did 
not experience good continuity of care. About 60% of the SMHC patients have a quality rating 
of 2. This demonstrates that the majority of the SMHC patients received psychotherapy treatment 
for 45 minutes or longer. In addition, 23.1% of the SMHC patients have a quality rating of 3 or 
higher - an improved result compared to PMHC. This might show that the resources provided by 
SMHC improve the quality of psychotherapy treatments provided. 
 
Table 11: PTSD Psychotherapy Quality Ratings by Highest Level of Care Received 
The percentage of patients who visited only primary care (46.8%) and the percentage of 
the patients who visited all three care settings (47.6%) are approximately the same. This result 
differs from the MDD patient population who mostly visited primary care for psychotherapy 
treatments. PMHC patients who are represented by red data series in Figure 10 only form a small 
percentage of the PTSD patient population. None of these patients have quality ratings higher 
than 2.  
PTSD
0 177 98.88% 6 28.57% 8 4.40% 191 50.00%
1 2 1.12% 9 42.86% 24 13.19% 35 9.16%
2 0 0.00% 6 28.57% 108 59.34% 114 29.84%
3 0 0.00% 0 0.00% 19 10.44% 19 4.97%
4 0 0.00% 0 0.00% 12 6.59% 12 3.14%
5 0 0.00% 0 0.00% 11 6.04% 11 2.88%
Total 179 100.00% 21 100.00% 182 100.00% 382 100.00%
Care Setting
TangScale
PC PC+PMHC PC+PMHC+SMHC Total
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Figure 10: PTSD Psychotherapy Quality Ratings by Highest Level of Care Received 
Medication and Psychotherapy Combined Quality Ratings 
To determine the overall quality of mental health treatments, we combined the quality 
ratings for medication and psychotherapy treatments and analyzed them separately for MDD and 
PTSD patient populations. Alcohol abuse does not need psychotherapy treatment; therefore, no 
combined quality rating analyses exist for alcohol abuse. For MDD patients, the data showed that 
64.4% of them attended only primary care and only 3.8% of them visited both primary care and 
PMHC. This result clearly shows that the majority of the MDD patients attended primary care to 
utilize mental health services; however 54.8% of these attendants did not receive any mental 
health treatment. The twenty PMHC patients seem to receive better care since 45% of them are 
assigned quality ratings of 4 or 5. For SMHC, the data yields even better results where 64.7% of 
the patients had a quality rating of 4 or 5 and only 1.2% of the patients were untreated. 
 
Table 12: MDD Quality Ratings by Highest Level of Care Received 
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As it can be clearly seen from Figure 11, more than half of the patients who attend 
primary care only are not receiving any treatment after being identified with a new mental health 
disorder. In addition, the percentage of patients who attended all three clinics significantly grows 
as the quality ratings increase. Almost no patients have with a quality rating of 3 because they 
were upgraded to quality rating of 4 or 5. This result shows that the MDD patients who received 
a sufficient total daily dose of medication were also treated for an adequate duration. In addition, 
the patients who received psychotherapy with the same provider were also treated over an 
adequate duration. 
 
Figure 11: MDD Quality Ratings by Highest Level of Care Received 
For PTSD patients, 46.8% of the total population attended primary care; however only 
10.6% of these patients received treatment with quality rating of 4 or 5. Approximately 57% of 
the PTSD patients who were seen in primary care were not treated for their condition. Only 5.5% 
of the PTSD patients attended both primary care and PMHC which is a result similar to that of 
MDD patients. The patients who attended all three clinics form 47.6% of the PTSD patient 
population and 51.1% of them received care with a quality rating of 4 or 5. Only 1.1% of the 
PTSD patients who attended all three clinics did not receive any treatment - significantly lower 
than the patients who only attended primary care. These results show that as patients received 
treatments in more care settings the quality of care they received was improved.  
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Table 13: PTSD Quality Ratings by Highest Level of Care Received 
Similar to the MDD patients, the majority of the PTSD patients who visited primary care 
did not receive any treatment as shown by Figure 12. Each quality rating has patients who visited 
all three clinics as shown by the green data series. Quality ratings of 2 and 5 have the highest 
percentage of patients who visited all three care settings. In contrast to the MDD patients, there 
are PTSD patients with quality rating of 3 who were not upgraded to quality rating of 4. This 
result shows that the suggested treatment durations were not satisfied for these patients.  
 
Figure 12: PTSD Quality Ratings by Highest Level of Care Received 
4.3 Simulation Results 
Table 14 highlights the patient wait times generated by the simulation model based on the 
White River Junction clinic. Comparing the results of Base Scenario and Increased Volume (in 
Table 18) shows that patients would have to wait less than 5 additional minutes to talk to clerk or 
use a tablet. In this case, it is unjustifiable to add one more clerk or tablet so we decided not to 
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increase the number of clerks and tablets in additional scenarios. The table also shows that the 
care manager would take approximately 40 more hours to review patient files and follow up with 
them. Since the care manager usually takes a few weeks before following up a patient and 
patients do not have to wait physically in the clinic, we also decided to keep the number of care 
managers the same in other scenarios.  
 
Table 14: Patient Wait Times (in minutes) for different resources of PMHC 
Patient wait times for prescribers and therapists increased significantly—more than 
double of the current wait times; therefore, we ran two scenarios with additional prescribers and 
therapists. Additional Prescriber and Therapist I has 2 prescribers and 2 therapists while 
Additional Prescriber and Therapist II has 3 prescribers and 3 therapists (Base Scenario and 
Increased Patient Volume have only 1 prescriber and 1 therapist.) Patient waiting times for 
prescribers and therapists in four different scenarios are illustrated in Figure 13 below. 
 
Figure 13: Patient Wait Times (in minutes) to see Prescriber and Therapist 
Base Scenario
Increased Patient 
Volume
Additional Prescriber 
and Therapist I
Additional Prescriber 
and Therapist II
Prescriber 36.7 ± 0.6 85.6 ± 0.6 41.4 ± 0.6 20.9 ± 0.6
Therapist 29.4 ± 0.6 78.6 ± 0.6 26.7 ± 0.6 12.1 ± 0.0
Clerk 0.9 ± 0.0 5.0 ± 0.0 4.9 ± 0.0 5.0 ± 0.0
Tablet 0.1 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0
Care Manager 298.2 ± 3.6 339.6 ± 2.4 431.4 ± 4.2 556.9 ± 22.2
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Table 15: Utilization of PMHC Resources for Patient Treatment 
Table 15 shows the utilization of PMHC resources in different scenarios. With increased 
patient volume, the clerk, tablets, and care manager would be much busier but these increases 
would not be an issue since their utilization levels are not concerning. However, the prescriber 
and therapist would be busy over 80% of the time causing increased wait times for patients. 
Figure 14 illustrates how the utilization of the prescriber and therapist changed in four scenarios. 
 
Figure 14: Utilization of Prescriber 
 
Base Scenario
Increased Patient 
Volume
Additional Prescriber 
and Therapist I
Additional Prescriber 
and Therapist II
Prescriber 53.23% 85.80% 74.09% 58.89%
Therapist 34.94% 80.19% 57.33% 40.11%
Clerk 15.00% 45.62% 45.41% 45.52%
Tablet 11.37% 34.95% 34.77% 34.88%
Care Manager 24.43% 48.44% 71.06% 78.64%
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Figure 15: Utilization of Therapist 
As shown in Figure 15, adding 1 additional prescriber and therapist each (Additional Prescriber 
and Therapist I scenario), the clinic should be able to serve a patient volume which is 
approximately 3 times that of the current volume without causing patients to wait significantly 
longer. However, the utilization of prescribers and therapists would increase by slightly more 
than 20 percent. As another option, adding 2 additional prescribers and therapists each 
(Additional Prescriber and Therapist II scenario) would keep the utilization near the current 
level. This scenario also reduces patient wait times to less than the current wait times. 
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5. Discussion 
5.1 Quality Scale 
 The results of our analyses on the quality scales showed that the majority of patients 
received care solely in the primary care setting and the second largest group of patients who 
received care were the ones who attended all three clinics. A very underwhelming number of 
patients in our target population utilized services offered by primary care and PMHC without 
subsequently attending SMHC. 
While categorizing patients by mental health medication or psychotherapy, specifically 
for PTSD patients, there are more patients treated in all three care settings. As expected, most of 
the patients who have a quality rating of 4 or higher are seen in SMHC which provides extensive 
mental health services. This result aligns with the assumption that patients who benefit from the 
most extensive mental health services at SMHC would receive the most adequate and highly-
qualified mental health treatment. 
 The results also show that the majority of patients in our target population who test 
positive for a mental health disorder and receive no treatment are being treated solely in primary 
care. The reason for this may be that patients are unwilling or not yet willing to seek further 
treatment. It also may be that the patients are testing positive for certain mental health screens; 
however, their PCPs do not believe that the patient has a problem and do not refer the patient to 
PMHC (e.g. 2,060 out of 2,494 patients in our target population were seen solely in primary care 
and did not receive any mental health medication even though they tested positive for alcohol 
abuse).   
5.2 Simulation 
Determining the number of additional staff needed for the PMHC clinic depends on VA 
Medical Center’s approach to improving the mental health services. Adding 1 additional 
prescriber and therapist each as shown in Additional Prescriber and Therapist I scenario allows 
the clinic to serve 3 times as many patients. However such a change would increase the 
utilization of prescribers and therapists and the staff members would need to eliminate non-value 
added tasks in order to create 20% more time of the work day to treat patients. This change will 
most likely be difficult to implement until the non-value added, time-consuming tasks are 
determined and eliminated. 
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On the other hand, if the PMHC clinic adds 2 new prescribers and 2 therapists as shown 
in the Additional Prescriber and Therapist II scenario, the utilization of the staff would stay 
around the current level and the patient wait times would be reduced. Although such a change 
would improve patient experience, it would also create a significant expense for the clinic due to 
paying for 4 new employees.  
The decision to add 1 prescriber and 1 therapist or 2 prescribers and therapists depends 
on VA’s perspective on the matter. Adding 1 of each specialist may prove to be more cost 
effective than adding 2 of each. If the officials prioritize expenses as an important factor in the 
decision making, then selecting Additional Prescriber and Therapist I with 1 additional 
prescriber and 1 additional therapist would be logical. If they prioritize improving patient 
experience, Additional Prescriber and Therapist II would be suitable to address the issue. 
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6. Recommendations 
6.1 Assessment of the Severity of Health Conditions  
This project did not consider the severity of patients’ mental health conditions. As a next 
step, patients should be grouped by how sick they are, to identify whether patients who need to 
be treated are being treated and what medication and psychotherapy ratings are. By stratifying 
patients by severity of their mental health conditions, patients who should but are not meeting the 
recommended daily doses can be identified. In order to determine how severe patients’ health 
conditions are, there are different scores that can be used.   
From the yearly screenings for mental health disorders, patients are assigned a score 
which may be a proxy for their severity of the specific mental health disorder being tested. 
Although these tests have specific scales to identify the severity of illnesses, the results are not 
completely accurate due to the subjectivity incorporated in the tests. Patient demographics, the 
expertise and approach of the physicians, and the conditions in the medical facilities all impact 
the scores assigned to patients [21]. The Charlson Comorbidity Index is an objective score that 
PCPs use to evaluate the severity of illnesses and mortality level in their patients. This index 
assigns scores to patients for each disease that is likely to reduce their lifetime. Scores are 
assigned for each chronic disease of the patient such as diabetes, heart failure or metastasis, and 
they are then added together to obtain a final score that represents the mortality level of a patient. 
These assessments are crucial for prioritizing patients in receiving treatment when the available 
resources are not sufficient. If the costs and risks of treatment outweigh the benefit from the 
treatment, then the resources offered to a patient with severe conditions might be transferred to a 
patient with a lower mortality score [22].  
6.2 Quality Scale  
After presenting the results to our sponsor, it became clear that the categorization of 
patients by highest care setting may not be accurate. Although patients may majority of their care 
in PMHC, if they went to the SMHC even just once, they were categorized as SMHC. We 
recommend re-evaluating the SMHC patients to see whether they receive more mental health 
care in PMHC or SMHC. Further analysis should also be made on the patients who are not 
receiving any mental health treatment (medication and psychotherapy). 
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Another recommendation with regards to the quality scale is the use of automated text 
parsing using tools such as regular expression for future (larger) data sets to convert the SIGs to 
useful numbers.   
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Industrial Engineering MQP Design Component 
The section below provides an overview of the design process for our methodology and 
constraints involved in our project as well as the life-long learning skills we achieved through its 
duration.  
Design 
We identified the problem at the VA mental health services as the lack of an established 
system that can track the quality of care provided as well as the necessity to identify the 
workforce needed in order to serve a larger patient population at the PMHC clinic. Our solution 
to the problem was built upon previous work completed by two of our team members as well as 
research conducted by our project sponsor Dr. Shiner. We established our objectives as to assist 
the VA in analyzing their patient population for quality purposes while recommending the 
workforce needed to maintain a certain quality level at the PMHC clinic to treat more patients.   
The methods utilized to address the problem included extensive data analysis and simulation 
modeling. The first component of our methodology was the quality scale we utilized to 
categorize VA mental health patients into different quality ratings. In order to do so, we first 
identified our target population as the patients who screened positive in FY 2011, but did not 
receive the adequate amount of mental health treatment (1 inpatient encounter or 2 outpatient 
encounters) in FY 2010. These patients were screened for post-traumatic stress disorder (PTSD), 
mental depressive disorder (MDD) and alcohol abuse - which are the three most common mental 
disorders among VA patients. We considered the patients who visited only the following care 
settings when we formed the target population: PC only, PC and PMHC only, PC, PMHC, and 
SMHC together. The criteria used for the quality scale varied depending on the type of mental 
health disorder—MDD, PTSD, and Alcohol Abuse—and the type of treatment—medication and 
psychotherapy. 
The patients in our target population were first examined to determine whether their 
treatments satisfy the quality rating 1 criteria for medication and psychotherapy separately. As 
some treatments satisfied the additional criteria for higher quality ratings, the patients who 
received those treatments were assigned higher ratings. This process was implemented in a 
fashion similar to climbing up a pyramid where the dataset for each higher quality rating was 
derived from the quality rating one below. 
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The second part of our project was focused on modifying a simulation model to analyze the 
patient wait times and staff utilization at the PMHC clinic. This model was created by two of the 
team members during the summer of 2012 as part of another VA project. We created four 
different simulation scenarios to identify the number of extra personnel needed in order to treat 
more patients while preserving a certain quality level at the clinic. The first scenario was the base 
scenario which used the current values for patient arrival rate and resource capacity that were 
observed at the PMHC clinic. The second scenario was named as the ‘Increased Patient Volume’ 
and reflected the extreme case of having three times as many patient arrivals while maintaining 
the current staffing level. The third scenario analyzed the impact of adding 1 prescriber and 1 
therapist to the clinic in order to serve the incoming patients whose arrival rate was increased to 
3 times of the current rate. The last scenario also looked into satisfying increased demand while 
utilizing 2 additional prescribers and 2 additional therapists. The scenarios were compared and 
contrasted to analyze their impact on patient wait times and staff utilization. 
Constraints 
This project required extensive data cleansing, compilation and analysis which was difficult 
to complete during the available time span. We started working on the project in September 2012 
and completed our analysis by the end of March 2013. However, the project goals and objectives 
constantly evolved and more analysis became necessary during various phases of the project. For 
this reason, the time available to complete the project and create a valuable end product was a 
serious constraint. In order to address this difficulty, we had regular conference calls and email 
contact with our sponsors to discuss progress as well to answer quick questions.  
 Gathering all the data attributes we needed was a complicated task. We had to compile 
patient visits, patient demographics and pharmacy data together in a meaningful way by using 
queries. We first identified which exact data attributes we needed after observing the clinics and 
having discussions with the project sponsors. We constantly communicated with the New 
England Veterans Engineering Resource Center (VERC) in order to acquire the necessary data 
from the central data warehouse of the VA. This procedure slowed down our progress because 
we could not access and compile the data directly due to privacy constraints. The mental health 
records of VA patients are confidential; thus all the data attributes that belonged to our patient 
population had to be de-identified before we ran our analysis.  
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 Another constraint we faced was the reproducibility of our data analysis procedure. This 
is due to the unique collocated model implemented at the White River Junction Medical Center. 
Many other VA medical centers treat their patients separately at primary clinic and specialized 
clinic without utilizing an integrated clinic as a gateway. For this reason, the information flow 
and the interaction between the clinics differ from how the system works at the WRJ VA 
Medical Center. This situation contradicts with our initial goal: to design a procedure that was 
easy to replicate at other VA medical centers. Although the data analysis procedure we used 
cannot be exactly implemented at other clinics, it can easily be repeated at the VA Medical 
Center for future analysis.  
Life-Long Learning 
This project helped our team members to gain certain technical skills as well as 
leadership and project management skills. As we started the project and were not knowledgeable 
enough about the VA system, we invested significant time into researching the collocated model 
and mental health services provided at the VA medical centers. This preliminary phase of the 
project taught us how to effectively research background information about a system in order to 
create a problem statement and potential solution path. Doing effective research involved 
observing the operations at the three clinics within the WRJ Medical Center. During this time, 
we learned how to ask the right questions, collect relevant information and interpret such 
information to build a solution.  
One important aspect of the life-long improvement process was learning how to manage 
resources in an efficient way. In order to be resourceful, we identified which individuals have the 
necessary experience and knowledge to tackle certain tasks. Our sponsor Dr. Shiner who is a 
researcher psychiatrist knew the VA system very well and therefore guided us through 
identifying problems as well as leading us in the right direction for designing solutions. We also 
had two team members who had previous project experience with extensive data analysis and 
simulation modeling who took a lead on these tasks which were the backbones of the project. 
This project experience taught us how to identify the individual strengths of team members so 
they can work together effectively to achieve a common goal.  
Another important skill we achieved through this project was being able to develop 
foresight as to which direction our project should head in. As we continued to analyze data and 
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communicate with our sponsors, we started to understand how this project fits within the “big 
picture”: what changes can be implemented at the VA in order to improve the mental health 
services? Our project provided the VA administration with preliminary information on the 
quality of mental health care provided. 
The VA administration is looking into identifying the roles of different care settings for 
mental health treatment. For this reason, their focus is on understanding the function of the 
PMHC clinic within the system. The main question they wish to answer is: Should most mental 
health patients be treated at the PMHC or should the clinic serve as a gateway between primary 
care and specialized mental health care? Our project provided the VA officials with a 
preliminary analysis which will allow them to answer this question in the long-term. We 
assessed the overall quality of mental health care provided as well as staffing changes needed at 
the PMHC clinic. Thus, we completed some essential analysis which will assist the VA 
administration to strategize their mental health services to provide the best care possible.  
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7. Conclusions 
This report addresses the need for a quality measure on mental healthcare in the VA. 
While literature has stated that receiving mental health care in PMHC is better than in solely PC, 
there are no data driven numbers to support this claim. Although the findings show that most 
patients who are not receiving care go only to the PMHC, it does show that the PMHC may be a 
facilitator for patients to be seen and receive better care in SMHC. The former statement is not 
for certain; we categorized by the highest level of care a patient received. More extensive 
analysis needs to be done on which care setting is where the majority of individual patients’ 
mental health care is treated. The current numbers are not enough for a conclusive argument 
about whether patients have higher quality scores if they go to PMHC along with PC.  
The report also addresses what would happen if all the patients not currently seen in 
PMHC visit the PMHC clinic. The team adjusted parameters in the PMHC simulation model that 
was build prior to the project by two of the team members along with the help of the WRJ 
doctors and staff, New England VERC engineers and cooperative students from Northeastern 
University. Using scenario analysis, the team determined that the best scenario to counteract the 
influx in patient volume is to staff two prescribers and two therapists to keep the wait times for 
patients to see a provider similar to the times before the increase in patients to the PMHC.   
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Appendix A: Summary of Raw Data Tables  
Working with engineers at the VERC, we pulled data that were categorized into the following 
tables: 
Table Name Relevant Data Fields  Used For 
tblPtDem PatientSID (patient identifier) 
Gender 
Marital Status 
Age 
Race 
Date of Birth 
Deceased/Alive 
DateofDeath 
Veteran/Non-Vet 
CurrentMeansTestStatusIEN  
(financial need indicator) 
PercentServiceConnect 
PeriodofService 
TestPatientFlag (not real patients; 
used for studies, etc.) 
County 
State 
Sta3n (location of care)
1
 
Understanding background 
information about our target 
population 
tblMHAssess_-_PHQ2 PatientSID 
SurveyGivenDateTime 
Raw Score 
Determining which patients 
tested positive in FY2011  
 
tblMHAssess_-_AUDC Same as above Determining which patients 
tested positive in FY2011 
tblMHAssess_-
_PC_PTSD 
Same as above Determining which patients 
tested positive in FY2011 
                                                          
1
 Every patient in this study should have Sta3n number 405 for White River Junction and its CBOCs. 
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tblMHAssess_-_PCLM Same as above Determining which patients 
tested positive in FY2011
2
 
tblMHAssess_-_PHQ9 Same as above Determining which patients 
tested positive in FY2011 
tblPharmData PatientSID 
RxOutpatSID (visit identifier) 
MaxRefill 
IssueDate 
DispensedDate 
Quantity 
SIG (doctors’ notes, when/how much 
to take) 
DrugNameWithoutDoseSID (drug 
identifier) 
NationalFormularyName (drug name) 
Strength (e.g. milligrams of the 
tablet) 
DispenseUnit (e.g. patch, tablet, 
capsule, injection) 
Determining what rating on the 
Tang Scale patients have for 
their specific MH disorder 
  
                                                          
2
 We included the PCLM and PHQ-9 tests in case there would not be enough patients who tested for the other 
three mental health (MH) assessments. After analyzing the data, we found that out of the 18,774 patients who 
took a MH survey in FY2011, 35 took ONLY the PHQ-9, 3 took ONLY the PCLM and 12 took both the PHQ-9 and 
PCLM and nothing else; therefore, we and our sponsors agreed that it was unnecessary to look at those tests with 
regards to our target population.  
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Appendix B: Mental Health Medications 
Table 16: List of Psychiatric Medications (Medication Rating 1 Criteria) 
ACAMPROSATE DIAZEPAM MEMANTINE RAMELTEON 
ALPRAZOLAM DISULFIRAM MEPROBAMATE RILUZOLE 
AMITRIPTYLINE DIVALPROEX MIDAZOLAM RISPERIDONE 
AMITRIPTYLINE/PERPHENAZI
NE 
DONEPEZIL MIRTAZAPINE RIVASTIGMINE 
AMOBARBITAL DOXEPIN MOLINDONE ROPINIROLE 
AMOXAPINE DULOXETINE NALTREXONE SECOBARBITAL 
ARIPIPRAZOLE ESCITALOPRAM NEFAZODONE SELEGILINE 
ATOMOXETINE ESZOPICLONE NORTRIPTYLINE SERTRALINE 
BUPROPION FLUOXETINE OLANZAPINE TEMAZEPAM 
BUSPIRONE FLUPHENAZINE OXAZEPAM THIORIDAZINE 
CARBAMAZEPINE FLURAZEPAM OXCARBAZEPIN
E 
THIOTHIXENE 
CHLORAL HYDRATE FLUVOXAMINE PALIPERIDONE TOPIRAMATE 
CHLORDIAZEPOXIDE GABAPENTIN PAROXETINE TRANYLCYPROMI
NE 
CHLORPROMAZINE GALANTAMINE PENTOBARBITA
L 
TRAZODONE 
CITALOPRAM GUANFACINE PERPHENAZINE TRIAZOLAM 
CLOMIPRAMINE HALOPERIDOL PHENELZINE 
SULFATE 
TRIFLUOPERAZINE 
CLONAZEPAM IMIPRAMINE PHENOBARBITA
L 
TRIMIPRAMINE 
CLONIDINE ISOCARBOXAZI
D 
PHENYTOIN VALPROATE 
SODIUM 
CLORAZEPATE LAMOTRIGINE PIMOZIDE VALPROIC ACID 
CLOZAPINE (CLOZARIL) LEVETIRACETA
M 
PRAMIPEXOLE VENLAFAXINE 
CLOZAPINE (MYLAN) LITHIUM PRAZOSIN ZALEPLON 
DESIPRAMINE LORAZEPAM PREGABALIN ZIPRASIDONE 
DESVENLAFAXINE LOXAPINE PROTRIPTYLINE ZOLPIDEM 
DEXMEDETOMIDINE MAPROTILINE QUETIAPINE  
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Appendix C: Logic for Assigning Quality Scores 
The charts below illustrate the logic behind the analysis to assign quality ratings to mental health patients. 
The first chart is specialized on medications and the second chart is specialized on psychotherapy which 
are the two treatment types that provide the criteria for quality ranks. 
 
Target Population
Received any 
psychiatric 
medication?
Received guideline-
recommended 
medication?
Received adequate 
daily dose?
Received medication 
for adequate 
duration?
Received adequate 
dose and duration for 
more than once?
Yes
Yes
Yes
Yes
Assign rating 0No
Assign rating 1No
Assign rating 2No
Assign rating 3No
Assign rating 4No
Assign rating 5
Yes
Target Population
Received 
psychotherapy 
treatment?
Received 
psychotherapy for 45 
minutes or greater?
Had 8 or more 
sessions with the 
same provider?
Had 8 or more 
sessions over 14 
week period?
Had two or more 
trials which satisfy 
all the above 
conditions?
Yes
Yes
Yes
Yes
Assign rating 0No
Assign rating 1No
Assign rating 2No
Assign rating 3No
Assign rating 4No
Assign rating 5
Yes
Every patient is assigned a 
quality rating between 0 and 5
Every patient is assigned a 
quality rating between 0 and 5
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Appendix D: Patient arrival rates to PMHC in FY 12 
Current   Intake Follow-up Call-back 
Monday 
7:00 - 8:00 0.133 0.267 0.022 
8:00 - 9:00 0.289 0.711 0.067 
9:00 - 10:00 0.422 1.000 0.156 
10:00 - 11:00 0.644 1.022 0.133 
11:00 - 12:00 0.533 1.356 0.178 
12:00 - 1:00 0.267 0.489 0.111 
1:00 - 2:00 0.422 0.578 0.067 
2:00 - 3:00 0.356 0.489 0.111 
3:00 - 4:00 0.400 0.533 0.244 
Tuesday 
7:00 - 8:00 0.038 0.615 0.038 
8:00 - 9:00 0.154 0.865 0.135 
9:00 - 10:00 0.365 1.096 0.096 
10:00 - 11:00 0.404 1.173 0.135 
11:00 - 12:00 0.615 0.885 0.115 
12:00 - 1:00 0.212 0.500 0.154 
1:00 - 2:00 0.346 1.192 0.096 
2:00 - 3:00 0.327 1.000 0.058 
3:00 - 4:00 0.231 0.635 0.173 
Wednesday 
7:00 - 8:00 0.041 0.163 0.041 
8:00 - 9:00 0.184 0.429 0.020 
9:00 - 10:00 0.265 1.000 0.143 
10:00 - 11:00 0.633 1.388 0.122 
11:00 - 12:00 0.592 0.796 0.082 
12:00 - 1:00 0.327 0.653 0.224 
1:00 - 2:00 0.204 1.184 0.204 
2:00 - 3:00 0.265 1.000 0.041 
3:00 - 4:00 0.143 0.592 0.163 
Thursday 
7:00 - 8:00 0.059 0.216 0.000 
8:00 - 9:00 0.216 0.784 0.118 
9:00 - 10:00 0.373 0.922 0.137 
10:00 - 11:00 0.392 1.039 0.157 
11:00 - 12:00 0.510 0.804 0.235 
12:00 - 1:00 0.275 0.647 0.059 
1:00 - 2:00 0.314 0.627 0.157 
2:00 - 3:00 0.451 0.569 0.196 
3:00 - 4:00 0.235 0.490 0.078 
Friday 
7:00 - 8:00 0.098 0.275 0.039 
8:00 - 9:00 0.196 0.804 0.118 
9:00 - 10:00 0.451 0.882 0.039 
10:00 - 11:00 0.529 0.941 0.137 
11:00 - 12:00 0.235 0.725 0.137 
12:00 - 1:00 0.333 0.667 0.020 
1:00 - 2:00 0.216 0.745 0.059 
2:00 - 3:00 0.216 0.490 0.137 
3:00 - 4:00 0.137 0.471 0.098 
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Appendix E: Simulation Model Screenshots 
 
Simulation Submodels 
 
Patient Arrive and Register Submodel 
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Treatment Types Received Submodel 
 
Patients See Providers Submodel Part 1 
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Patients See Providers Submodel Part 2 
 
Patients Leave and Clinic Closes Submodel 
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Care Manager Office Submodel 
 
Care Manager Follow Up Calls Submodel 
